Compare
Vycor Medical Inc vs EBR Systems, Inc. vs Femasys Inc vs QHSLab, Inc.
| Latest fiscal year | Vycor Medical Inc VYCO | EBR Systems, Inc. NONE. | Femasys Inc FEMY | QHSLab, Inc. USAQ |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.86M | $1.62M | $2.29M | $2.69M |
| Revenue growth (YoY) | +17.2% | n/a | +40.8% | +26.3% |
| Gross margin | 83.8% | 30.3% | 62.0% (computed) | 67.3% |
| Operating margin | 1.8% | n/m | -767.0% | 4.9% |
| Net margin | -3.9% | n/m | -812.3% | 17.0% |
| Net income | -$72.4K | -$48.76M | -$18.63M | $457.4K |
| EPS (Diluted) | -$0.01 | -$0.12 | -$0.47 | $0.02 |
| Operating cash flow | -$13.5K | -$53.19M | -$18.69M | $178.1K |
| Free cash flow | -$18.7K | -$56.88M | -$19.22M | n/a |
| Cash & equivalents | $87.0K | $5.79M | $9.27M | $636.2K |
| Total assets | $830.4K | $97.23M | $20.72M | $2.17M |
| Total liabilities | $4.92M | $71.64M | $14.85M | $546.1K |
| Shareholders' equity | -$4.09M | $25.59M | $5.87M | $1.62M |
| Return on year-end equity | n/a | -190.6% | -317.4% | 28.1% |
| Shares outstanding | 33.37M | 450.26M | 59.60M | 15.03M |
Revenue, most recent five fiscal years
| Fiscal year | Vycor Medical Inc | EBR Systems, Inc. | Femasys Inc | QHSLab, Inc. |
|---|---|---|---|---|
| Latest | $1.86M Ended 2025-12-31 | $1.62M Ended 2025-12-31 | $2.29M Ended 2025-12-31 | $2.69M Ended 2025-12-31 |
| 1 year earlier | $1.59M Ended 2024-12-31 | n/a | $1.63M Ended 2024-12-31 | $2.13M Ended 2024-12-31 |
| 2 years earlier | $1.46M Ended 2023-12-31 | n/a | $1.07M Ended 2023-12-31 | $1.41M Ended 2023-12-31 |
| 3 years earlier | $1.22M Ended 2022-12-31 | n/a | $1.21M Ended 2022-12-31 | $1.24M Ended 2022-12-31 |
| 4 years earlier | $1.39M Ended 2021-12-31 | n/a | $1.18M Ended 2021-12-31 | $1.41M Ended 2021-12-31 |